Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Vilcek
Bruce N Cronstein

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
A prize for the foreign-bornJan Vilcek, Bruce N Cronstein
F1000 Biology Reports|October 18, 2011
Adenosine receptors and fibrosis: a translational reviewBruce N Cronstein
Arthritis Research & Therapy|August 26, 2010
A personal journey from the joint to the heartBruce N Cronstein
Pharmacological Reviews|May 26, 2005
Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritisBruce N Cronstein
Arthritis and Rheumatism|April 9, 2005
Folic acid and folinic acid supplements and methotrexate therapy: comment on the article by Morgan et alBruce N Cronstein
Nature Clinical Practice. Rheumatology|August 26, 2006
Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute coutureBruce N Cronstein
Nature Clinical Practice. Rheumatology|March 22, 2007
Do elevated red blood cell methotrexate polyglutamate levels predict methotrexate efficacy?Bruce N Cronstein
Bulletin of the NYU Hospital for Joint Diseases|November 24, 2006
Pharmacogenetics in the rheumatic diseasesBruce N Cronstein
Bulletin of the NYU Hospital for Joint Diseases|October 10, 2007
Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritisBruce N Cronstein
Nature Clinical Practice. Rheumatology|November 30, 2006
Do genetic variations in the adenosine pathway affect patient response to methotrexate?Bruce N Cronstein
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
A prize for the foreign-bornJan Vilcek, Bruce N Cronstein
F1000 Biology Reports|October 18, 2011
Adenosine receptors and fibrosis: a translational reviewBruce N Cronstein
Arthritis Research & Therapy|August 26, 2010
A personal journey from the joint to the heartBruce N Cronstein
Pharmacological Reviews|May 26, 2005
Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritisBruce N Cronstein
Arthritis and Rheumatism|April 9, 2005
Folic acid and folinic acid supplements and methotrexate therapy: comment on the article by Morgan et alBruce N Cronstein
Nature Clinical Practice. Rheumatology|August 26, 2006
Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute coutureBruce N Cronstein
Nature Clinical Practice. Rheumatology|March 22, 2007
Do elevated red blood cell methotrexate polyglutamate levels predict methotrexate efficacy?Bruce N Cronstein
Bulletin of the NYU Hospital for Joint Diseases|November 24, 2006
Pharmacogenetics in the rheumatic diseasesBruce N Cronstein
Bulletin of the NYU Hospital for Joint Diseases|October 10, 2007
Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritisBruce N Cronstein
Nature Clinical Practice. Rheumatology|November 30, 2006
Do genetic variations in the adenosine pathway affect patient response to methotrexate?Bruce N Cronstein
Pageof 18